Managing Lupus Nephritis in Children and Adolescents
- 20 December 2023
- journal article
- review article
- Published by Springer Nature in Pediatric Drugs
- Vol. 26 (2) , 145-161
Abstract
Lupus nephritis is an important manifestation of systemic lupus erythematosus, which leads to chronic kidney disease, kidney failure, and can result in mortality. About 35%–60% of children with systemic lupus erythematosus develop kidney involvement. Over the past few decades, the outcome of patients with lupus nephritis has improved significantly with advances in immunosuppressive therapies and clinical management. Nonetheless, there is a paucity of high-level evidence to guide the management of childhood-onset lupus nephritis, because of the relatively small number of patients at each centre and also because children and adolescents are often excluded from clinical trials. Children and adults differ in more ways than just size, and there are remarkable differences between childhood- and adult-onset lupus nephritis in terms of disease severity, treatment efficacy, tolerance to medications and most importantly, psychosocial perspective. In this article, we review the ‘art and science’ of managing childhood-onset lupus nephritis, which has evolved in recent years, and highlight special considerations in this specific patient population.Keywords
This publication has 121 references indexed in Scilit:
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsAnnals of the Rheumatic Diseases, 2013
- Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosusArthritis Care & Research, 2011
- Three Decades of Progress in Treating Childhood-Onset Lupus NephritisClinical Journal of the American Society of Nephrology, 2011
- Predictors of Relapse and End Stage Kidney Disease in Proliferative Lupus NephritisClinical Journal of the American Society of Nephrology, 2009
- Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipientsJournal of Pharmacokinetics and Pharmacodynamics, 2009
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2009
- Differences in long‐term disease activity and treatment of adult patients with childhood‐ and adult‐onset systemic lupus erythematosusArthritis Care & Research, 2008
- Rituximab therapy for juvenile-onset systemic lupus erythematosusPediatric Nephrology, 2007
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant RecipientsClinical Pharmacokinetics, 2007
- Cyclosporin Pharmacokinetics in Paediatric Transplant RecipientsClinical Pharmacokinetics, 1997